STOP-HSP.net: An Italian Formal Registry for Clinical Trial Readiness in Hereditary Spastic Paraplegias

Overview

Journal Neurol Sci

Specialty Neurology

Date 2025 Feb 22

PMID 39985651

Authors

Sara Satolli

Salvatore Rossi

Leonardo Boccuni

Andrea Martinuzzi

Olimpia Musumeci

Giovanni Rizzo

Elisa Rossi

Gabriella Silvestri

Filippo Maria Santorelli

Affiliations

Soon will be listed here.

References

Shribman S, Reid E, Crosby A, Houlden H, Warner T . Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. Lancet Neurol. 2019; 18(12):1136-1146. DOI: 10.1016/S1474-4422(19)30235-2. View

Bellofatto M, De Michele G, Iovino A, Filla A, Santorelli F . Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature. Front Neurol. 2019; 10:3. PMC: 6349696. DOI: 10.3389/fneur.2019.00003. View

Vogt L, Quiroz V, Ebrahimi-Fakhari D . Emerging therapies for childhood-onset movement disorders. Curr Opin Pediatr. 2024; 36(3):331-341. PMC: 11047116. DOI: 10.1097/MOP.0000000000001354. View

Ruseckaite R, Mudunna C, Caruso M, Helwani F, Millis N, Lacaze P . Current state of rare disease registries and databases in Australia: a scoping review. Orphanet J Rare Dis. 2023; 18(1):216. PMC: 10373259. DOI: 10.1186/s13023-023-02823-1. View

Tarride J, Okoh A, Aryal K, Prada C, Milinkovic D, Keepanasseril A . Scoping review of the recommendations and guidance for improving the quality of rare disease registries. Orphanet J Rare Dis. 2024; 19(1):187. PMC: 11075280. DOI: 10.1186/s13023-024-03193-y. View

Sangiorgi L, Boarini M, Mordenti M, Wang V, Westerheim I, Skarberg R . SATURN: assessing the feasibility of utilising existing registries for real-world evidence data collection to meet patients, regulatory, health technology assessment and payer requirements. Orphanet J Rare Dis. 2024; 19(1):336. PMC: 11391597. DOI: 10.1186/s13023-024-03341-4. View

Rossi S, Rubegni A, Riso V, Barghigiani M, Bassi M, Battini R . Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network. Neurol Genet. 2022; 8(2):e664. PMC: 8969300. DOI: 10.1212/NXG.0000000000000664. View

Malina J, Huessler E, Jockel K, Boog-Whiteside E, Jeschonneck N, Schroder B . Development and validation of TreatHSP-QoL: a patient-reported outcome measure for health-related quality of life in hereditary spastic paraplegia. Orphanet J Rare Dis. 2024; 19(1):2. PMC: 10763482. DOI: 10.1186/s13023-023-03012-w. View

Traschutz A, Fleszar Z, Hengel H, Klockgether T, Erdlenbruch F, Falkenburger B . FARS-ADL across Ataxias: Construct Validity, Sensitivity to Change, and Minimal Important Change. Mov Disord. 2024; 39(6):965-974. DOI: 10.1002/mds.29788. View

10.

Diella E, DAngelo M, Stefan C, Girardi G, Morganti R, Martinuzzi A . Validation of the Italian version of a patient-reported outcome measure for Hereditary Spastic Paraplegia. PLoS One. 2024; 19(4):e0301452. PMC: 10984402. DOI: 10.1371/journal.pone.0301452. View